Oxprenolol hydrochloride - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for oxprenolol hydrochloride and what is the scope of patent protection?

Oxprenolol hydrochloride is the generic ingredient in one branded drug marketed by Novartis and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Summary for oxprenolol hydrochloride

US Patents:	0
Tradenames:	1
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	79
Patent Applications:	942
DailyMed Link:	oxprenolol hydrochloride at DailyMed

Medical Subject Heading (MeSH) Categories for oxprenolol hydrochloride

Adrenergic beta-Antagonists
Anti-Anxiety Agents
Anti-Arrhythmia Agents
Antihypertensive Agents
Sympatholytics
Vasodilator Agents

Anatomical Therapeutic Chemical (ATC) Classes for oxprenolol hydrochloride

C07AA	Beta blocking agents, non-selective
C07A	BETA BLOCKING AGENTS
C07	BETA BLOCKING AGENTS
C	Cardiovascular system

US Patents and Regulatory Information for oxprenolol hydrochloride

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Novartis	TRASICOR	oxprenolol hydrochloride	CAPSULE;ORAL	018166-001	Dec 28, 1983		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Novartis	TRASICOR	oxprenolol hydrochloride	CAPSULE;ORAL	018166-003	Dec 28, 1983		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Novartis	TRASICOR	oxprenolol hydrochloride	CAPSULE;ORAL	018166-004	Dec 28, 1983		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for oxprenolol hydrochloride

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Novartis	TRASICOR	oxprenolol hydrochloride	CAPSULE;ORAL	018166-002	Dec 28, 1983	⤷ Sign Up	⤷ Sign Up
Novartis	TRASICOR	oxprenolol hydrochloride	CAPSULE;ORAL	018166-004	Dec 28, 1983	⤷ Sign Up	⤷ Sign Up
Novartis	TRASICOR	oxprenolol hydrochloride	CAPSULE;ORAL	018166-003	Dec 28, 1983	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.